Target intelligence / Profile preview

SMYD3 intronic transcript 1 (SMYD3-IT1)

Target: SMYD3-IT1
Molecular classification: Other (non-coding RNA)

Overview

SMYD3 intronic transcript 1 (SMYD3-IT1) is a non-coding RNA (ncRNA) gene annotated in humans, originating from the intronic region of the SMYD3 gene. Unlike the protein-coding SMYD3, which functions as a histone methyltransferase and is implicated in various biological processes and cancers, SMYD3-IT1 itself does not encode a protein product. Current resources catalog SMYD3-IT1 as an RNA gene, but do not attribute characterized functions, disease roles, or direct pharmacological targeting to this transcript. The core therapeutic target in cancer and myogenesis biology is the protein-coding SMYD3, not SMYD3-IT1. SMYD3-IT1 is present as a gene entry in genomic databases, but there is no evidence that it is a receptor, enzyme, transporter, or established drug target. No drugs, mechanisms, biomarkers, or safety issues are reported for SMYD3-IT1 as an isolated molecular entity. If you meant the protein-coding SMYD3, see results above for its extensive role as an epigenetic regulator and cancer target; SMYD3-IT1 should not be conflated with the enzymatic, druggable SMYD3 protein.

Other names: SMYD3-IT1SMYD3 Intronic Transcript 1

Biological functions

Unknown (non-coding RNA; explicit biological function not established)

Disease associations

Unknown (no clear disease association established in current literature)

Beyond the preview

Go deeper on SMYD3 intronic transcript 1 (SMYD3-IT1).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Explore the programs pursuing this target and their development progress.

Drug candidates
Developers
Development stage

Clinical trials

Follow the clinical studies evaluating therapies directed at this target.

Trial design
Status
Readouts

Competitive landscape

Compare approaches across drug candidates, modalities, and indications.

Programs
Modalities
Indications

Literature & evidence

Investigate the research and source evidence behind target biology and development.

Publications
Sources
Analysis

Patents

Explore patent activity around therapies and technologies addressing this target.

Patents
Assignees
Technologies

Research & analysis

Connect target biology, drug development, and emerging evidence in your research.

Biology
Development news
Analysis

Bring the full picture into focus.

See how Gosset can support your research on SMYD3 intronic transcript 1 (SMYD3-IT1).

Explore the full profile